Inventory gain and loss, clear countermeasures, plan the new bureau company to deploy the next stage of production and operation work
Release time:
2021-04-21
News from our newspaper 2021 is the first year of the national "14th Five-Year Plan", and it is also an important year for the company to further deepen reforms and accelerate the pace of development. 4# April 15 and 16 , the company successively held work analysis meetings for pharmaceutical sector, cement sector and directly affiliated enterprises to summarize and take stock of the work gains and losses in the first quarter, requirements for this year's follow-up work, especially in the second quarter. At the
analysis meeting, the person in charge of each enterprise reported the work situation in the first quarter, focused on analyzing the existing problems, and put forward solutions and improvement plans. In the first quarter of this year, the impact of the new crown virus pneumonia epidemic in various parts of the country to varying degrees, the subordinate enterprises in seriously do a good job in the prevention and control of the epidemic at the same time, efforts to do a good job in production and operation, maintenance and technical reform, the work carried out in a smooth and orderly manner. At the work analysis meeting, chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work of each business sector one by one in combination with the economic and technical data of each enterprise in the first quarter, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements on how to further improve the work quality in the second three quarters of this year.
Peak Pharmaceutical Industry: Adjusting Thinking, Mending Shortcomings, Promoting Promotion
In view of various changes brought about by the reform of the national medical system in recent years and the current overall situation of the peak pharmaceutical industry, the meeting requires that the management of pharmaceutical companies should make more systematic plans for future work from the perspective of strategic development and constantly change their inherent thinking while doing a good job in daily production and operation management, find and make up for the short board of work, look for the gap against advanced enterprises, and constantly improve and upgrade. In terms of sales, it is necessary to carefully analyze the industry impact of centralized drug procurement and the country's in-depth rectification of the pharmaceutical industry, increase the innovation and reform of sales models and methods, closely track and timely evaluate current sales policies, and increase the control of market sales. Intensity. In terms of product research and development, while actively promoting the work related to consistency evaluation, it is necessary to further accelerate the construction of research and development platforms and continuously introduce new products with competitive advantages. As an important API base in the company's pharmaceutical sector, North Carolina and its subsidiaries should strengthen team building, unify thinking, unify actions, improve overall organizational capabilities and system management and control capabilities, and do each job carefully. City pharmaceutical companies and large pharmacies two pharmaceutical circulation enterprises, to do a stable sales, while paying attention to market changes, to seek breakthrough opportunities.
Cement Plate: Overall Control, Practice Internal Skills, Seize Opportunities
Affected by multiple factors, cement markets around the world have fluctuated to varying degrees since this year. In view of this situation, the meeting requires that the three cement enterprises under the company should further change their existing cognition and management concepts on the basis of their previous work, fully understand the gap between themselves and the excellent enterprises in the same industry, comprehensively improve their quality and ability from management cadres to ordinary employees, and achieve comprehensive control of the whole work process; constantly promote the application of digital and intelligent management means, continuously improve the reliability and stability of equipment and the effective operation rate of the system, and comprehensively improve labor productivity; strengthen the awareness of safety production, and grasp the management of safety and environmental protection; further optimize the organizational structure, improve the management level, practice internal skills, and create advantages, Seize development opportunities.
According to the specific conditions of various cement enterprises, the meeting required that Daye Peak should pay attention to the stability of the system operation after low-carbon transformation, do a good job in the preliminary preparation of the mechanism sand project, extend the industrial chain, and create new benefit growth points; Yunnan Peak should speed up the work related to mine remediation, do a good job in the production connection after the transformation of raw mill, further strengthen the production site remediation, and improve the stability and reliability of equipment operation, further strengthen marketing management to stabilize prices and markets; As a new enterprise, Huang Ping Jianfeng should do a good job in the quality management of mine raw materials, continuously optimize the batching scheme and cement grinding process parameters, reduce the clinker consumption of finished products, continuously improve and stabilize the product quality, reasonably carry out market planning, formulate effective marketing strategies according to the specific conditions of different regions, and improve the profitability of the enterprise.
In view of the new cement development project, the company requires to do a good job in promoting the relevant work to lay a good foundation for future development.
Peak Health: Clear the current situation, focus on the key points, and strive to break through
Peak Health Technology Company 2021 implemented a new round of management personnel contracting. After a quarter of work, obvious changes have been made and various operating indicators have improved. The meeting required the peak health management team to size up the situation, implement accurate policies, and strengthen market expansion and adjustment of marketing strategies. Subsequent product development should also focus on market channels and customer requirements, and carry out extended development while steadily improving existing market sales. Clarify the work direction, improve the overall management efficiency, earnestly implement the national management policy for health products, and operate in accordance with the law.
International Trade Company: Strengthen management, improve efficiency and control risks
In view of the operation and current business composition of international trade companies in the first quarter, the meeting requested international trade companies to strengthen coordination and management with enterprises entering the park, do a solid job in fire safety management of logistics parks, and provide the most basic guarantee for the operation and development of enterprises. Improve the standard of work management requirements, do a good job in the coordinated operation of the new information system and the original NC and dispatching system; Make good use of the government's support policies to speed up the construction of network logistics and car-free freight transportation platform; Continuously expand and introduce new business varieties to increase varieties to improve the overall business operation ability; Further increase the proportion of direct business and improve profitability; Strengthen the control of foreign trade business sectors and pay attention to preventing exchange rate risks; strengthen the application of modern management means and tools to promote the improvement of labor productivity.
Cable Company: Improve Quality, Reduce Cost, Improve Benefit
Cable Company achieved good operating results in the first quarter, and the overall operating conditions have improved significantly. The meeting asked cable companies to further strengthen equipment management in view of the current situation of the cable market, comprehensively improve the management level and technical level, while improving and stabilizing product quality, reduce costs by reducing the failure rate and unnecessary loss; pay close attention to the market price fluctuation of copper and other major raw materials, and follow the market to avoid market risks; seriously study the market and improve the ability to obtain information, efforts to improve domestic sales, direct sales and professional market sales, improve profitability, and strive for greater benefits.
(Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31